IMVT250417C00029000 Option on Immunovant

An 'Out of The Money' option on Immunovant has a strike price that Immunovant Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Immunovant's 'Out of The Money' options include buying the options if you expect a big move in Immunovant's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

Immunovant's Option Greeks for the contract ending on 2025-04-17 at a strike price of 29.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Immunovant's option greeks, its implied volatility helps estimate the risk of Immunovant stock implied by the prices of the options on Immunovant's stock.

Put options written on Immunovant grant holders of the option the right to sell a specified amount of Immunovant at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Immunovant Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Immunovant is like buying insurance aginst Immunovant's downside shift.

By selling Immunovant's put option, the investors signal their bearish sentiment. A short position in a put option written on Immunovant will generally make money when the underlying price is above the strike price. Therefore Immunovant's put payoff at expiration depends on where the Immunovant Stock price is relative to the put option strike price. The breakeven price of 29.5 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Immunovant's price. Finally, at the strike price of 29.0, the payoff chart is constant and positive.

Immunovant's option chain is a display of a range of information that helps investors for ways to trade options on Immunovant. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Immunovant. It also shows strike prices and maturity days for a Immunovant against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.